Comparison of combined oral contraceptive Yasmin and Cyproteron compound on Hirsutism and androgens in women with a polycystic ovary syndrome

Trial Profile

Comparison of combined oral contraceptive Yasmin and Cyproteron compound on Hirsutism and androgens in women with a polycystic ovary syndrome

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 14 Sep 2016

At a glance

  • Drugs Drospirenone/ethinylestradiol (Primary) ; Ethinylestradiol/cyproterone
  • Indications Hirsutism
  • Focus Pharmacodynamics
  • Most Recent Events

    • 15 Nov 2012 Status changed from recruiting to active, no longer recruiting as reported by Iranian Registry of Clinical Trials record.
    • 19 Apr 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top